Importantly, we showed for the first time that DCs treated with IL‐37 and TnI displayed a tolerogenic phenotype and that adoptive transfer of these antigen‐loaded tDCs markedly increased the number of Tregs, attenuated the infiltration of inflammatory cells, decreased myocardial fibrosis, and improved cardiac function. This evidence concerns the gene IL37 and Myocardial fibrosis.